Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma.
暂无分享,去创建一个
[1] R. Ballard,et al. Effect of sleep on nocturnal bronchoconstriction and ventilatory patterns in asthmatics. , 1989, Journal of applied physiology.
[2] A. Reinberg,et al. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. , 1987, Chronobiology international.
[3] C. Shapiro,et al. Sodium cromoglycate in nocturnal asthma. , 1986, Thorax.
[4] A. Reinberg,et al. Circadian rhythms in lung resistance and dynamic lung compliance of healthy children. Effects of two bronchodilators. , 1977, Respiration physiology.
[5] E. Shimizu,et al. Alteration of the Circadian Rhythm in Peak Expiratory Flow of Nocturnal Asthma Following Nighttime Transdermal β2‐adrenoceptor Agonist Tulobuterol Chronotherapy , 2005, Chronobiology international.
[6] D. Webb,et al. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[7] R. Buhl,et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. , 2006, Pulmonary pharmacology & therapeutics.
[8] R. Martin,et al. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. , 2011, The Journal of allergy and clinical immunology.
[9] T. Horiguchi,et al. Clinical Evaluation of a Transdermal Therapeutic System of the ß2-Agonist Tulobuterol in Patients with Mild or Moderate Persistent Bronchial Asthma , 2004, Arzneimittelforschung.
[10] H. Malmberg,et al. Anamnestic Data in Allergic Rhinitis , 1982, Allergy.
[11] R. Harrist,et al. Administration-time-dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children. , 1987, Chronobiology international.
[12] P. Nicholson,et al. Diurnal variation in the symptoms of hay fever: implications for pharmaceutical development. , 1973, Current medical research and opinion.
[13] W. R. Beam,et al. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. , 1992, The American review of respiratory disease.
[14] N. Masters. Death from asthma in two regions of England , 1982 .
[15] E. R. Sutherland,et al. Immunomodulatory effects of melatonin in asthma. , 2002, American journal of respiratory and critical care medicine.
[16] N. Douglas,et al. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.
[17] M. Smolensky,et al. Circadian rhythms in the cutaneous reactivity to histamine and selected antigens, including phase relationship to urinary cortisol excretion. , 1977, Annals of allergy.
[18] F. H. Tyler,et al. DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS. , 1965, The Journal of clinical endocrinology and metabolism.
[19] J. Ramsdell,et al. Once-daily evening administration of mometasone furoate in asthma treatment initiation. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[20] I. Rubinstein,et al. Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971]. , 2005, Clinical and molecular allergy : CMA.
[21] E. Israel,et al. Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. , 1999, The New England journal of medicine.
[22] A. Reinberg,et al. NOCTURNAL ASTHMA ATTACKS: THEIR RELATIONSHIP TO THE CIRCADIAN ADRENAL CYCLE. , 1963, The Journal of allergy.
[23] J. Earis,et al. Relationship between asthma and gastro-oesophageal reflux. , 1981, Thorax.
[24] R. Davies,et al. Recurrent nocturnal asthmatic reactions to bronchial provocation tests , 1979, Clinical allergy.
[25] R. Ballard,et al. Treatment of nocturnal asthma with pulsed-release albuterol. , 1992, Chest.
[26] R. Dahl,et al. The effect of salmeterol on the early‐ and late‐phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X , 1993, Allergy.
[27] E. R. Sutherland,et al. Elevated serum melatonin is associated with the nocturnal worsening of asthma. , 2003, The Journal of allergy and clinical immunology.
[28] R. Djukanović,et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. , 1999, American journal of respiratory and critical care medicine.
[29] M. Carruthers,et al. Nocturnal asthma and urinary adrenaline and noradrenaline excretion , 1977, Thorax.
[30] I. Adcock,et al. Formoterol attenuates neutrophilic airway inflammation in asthma. , 2005, Chest.
[31] B. Lipworth,et al. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids , 1999, Thorax.
[32] M. Affrime,et al. Influence of food on the absorption of albuterol Repetabs. , 1989, The Journal of allergy and clinical immunology.
[33] P. Christie. Ciclesonide: a novel inhaled corticosteroid for asthma. , 2004, Drugs of today.
[34] T. Young,et al. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. , 1997, The Journal of allergy and clinical immunology.
[35] T J Clark,et al. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. , 1980, Thorax.
[36] P. Forsham,et al. Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. , 1965, The New England journal of medicine.
[37] C. Persson. ROLE OF PLASMA EXUDATION IN ASTHMATIC AIRWAYS , 1986, The Lancet.
[38] D. Postma,et al. Effect of oral slow-release terbutaline on early morning dyspnoea , 2004, European Journal of Clinical Pharmacology.
[39] Douglas Nj. Asthma at night. , 1985 .
[40] Hiroko Watanabe,et al. Circadian Variation in Nasal Reactivity in Children with Allergic Rhinitis: Correlation with the Activity of Eosinophils and Basophilic Cells , 1999, International Archives of Allergy and Immunology.
[41] G. Persson,et al. Nocturnal asthma: effects of slow-release terbutaline on spirometry and arterial blood-gases. , 1988, The European respiratory journal.
[42] E. Kerwin,et al. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. , 2005, The Journal of allergy and clinical immunology.
[43] D. Postma,et al. Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction. , 1986, The Journal of allergy and clinical immunology.
[44] J. O'hanlon,et al. Seasonal allergic rhinitis and antihistamine effects on children's learning , 1992, European Neuropsychopharmacology.
[45] G. Persson,et al. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily. , 1988, The European respiratory journal.
[46] C. Dollery,et al. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. , 1980, The New England journal of medicine.
[47] G. D'Alonzo,et al. Circadian rhythms in the pharmacokinetics and clinical effects of beta-agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma. , 1999, Chronobiology international.
[48] A. Reinberg,et al. Circadian timing of methylprednisolone effects in asthmatic boys. , 1974, Chronobiologia.
[49] A. Reinberg,et al. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: Treatment implications☆☆☆★ , 1995, Journal of Allergy and Clinical Immunology.
[50] M. Meyer,et al. Relative bioavailability of a controlled‐release albuterol formulation for twice‐daily use , 1988, Biopharmaceutics & drug disposition.
[51] W. Busse,et al. Effects of Mometasone Furoate Given Once Daily in the Evening on Lung Function and Symptom Control in Persistent Asthma , 2005, The Annals of pharmacotherapy.
[52] S. Garattini,et al. Metabolism of exogenous cortisol in humans. I. Diurnal variation in plasma disappearance rate. , 1970, Biochemical pharmacology.
[53] L. Rosenwasser. New insights into the pathophysiology of allergic rhinitis. , 2007, Allergy and asthma proceedings.
[54] K. Hörmann,et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. , 2004, The Journal of allergy and clinical immunology.
[55] G. W. Thorn,et al. STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN. , 1963, The New England journal of medicine.
[56] G. D'Alonzo,et al. Day-night variation of airways status in sympathomimetic- and theophylline-treated asthma patients , 1993, The Journal of the American Osteopathic Association.
[57] H. Rundcrantz. Postural variations of nasal patency. , 1969, Acta oto-laryngologica.
[58] Grunstein Mm,et al. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. , 1982 .
[59] A. Reinberg,et al. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. , 1983, The Journal of allergy and clinical immunology.
[60] R. Ballard. Sleep, respiratory physiology, and nocturnal asthma. , 1999, Chronobiology international.
[61] F. Ducharme. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence , 2003, BMJ : British Medical Journal.
[62] R. Dockhorn,et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. , 1998, Archives of internal medicine.
[63] C. Page,et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.
[64] R. Ballard,et al. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. , 1989, The American review of respiratory disease.
[65] R. Pauwels,et al. Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.
[66] R. Pauwels,et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. , 1982, European journal of respiratory diseases. Supplement.
[67] K. Chung,et al. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.
[68] J. Malo,et al. Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. , 1992, The Journal of allergy and clinical immunology.
[69] A. Reinberg,et al. Euchronism, Allochronism, and Dyschronism: Is Internal Desynchronization of Human Circadian Rhythms a Sign of Illness? , 2007, Chronobiology international.
[70] J. Malo,et al. Sustained improvement in asthma with long-term use of formoterol fumarate. , 1992, Annals of allergy.
[71] A. Reinberg,et al. Twenty-four-hour rhythm in the bronchial hyperreactivity to house dust in asthmatics. , 1977, The Journal of allergy and clinical immunology.
[72] Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children. , 1987, Thorax.
[73] L. V. van Amelsvoort,et al. Vital Working Hour Schemes: The Dynamic Balance between Various Interests , 2006, Chronobiology international.
[74] A. Woolcock,et al. Nocturnal asthma: role of snoring and obstructive sleep apnea. , 1988, The American review of respiratory disease.
[75] K. Hörmann,et al. Mediators of inflammation in the early and the late phase of allergic rhinitis , 2004, Current opinion in allergy and clinical immunology.
[76] A. Williams,et al. The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma. , 1986, European journal of respiratory diseases. Supplement.
[77] G. Chrousos,et al. Decreased steroid responsiveness at night in nocturnal asthma. Is the macrophage responsible? , 2001, American journal of respiratory and critical care medicine.
[78] D. Postma,et al. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. , 1985, Chest.
[79] T. Reiss,et al. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. , 1998, The Journal of allergy and clinical immunology.
[80] The therapeutic potential of long‐acting β2‐adrenoceptor agonists in allergic inflammation , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[81] R. Pauwels,et al. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. , 1985, The Journal of allergy and clinical immunology.
[82] S. Lindgren,et al. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. , 1987, The Journal of allergy and clinical immunology.
[83] D. Mitchell,et al. Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. , 1981, British journal of clinical pharmacology.
[84] E. R. Sutherland,et al. Altered pituitary-adrenal interaction in nocturnal asthma. , 2003, The Journal of allergy and clinical immunology.
[85] J. Walters,et al. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. , 2002, The Cochrane database of systematic reviews.
[86] N. Jarjour. Circadian variation in allergen and nonspecific bronchial responsiveness in asthma. , 1999, Chronobiology international.
[87] R. Ballard,et al. Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. , 1990, The American review of respiratory disease.
[88] P. Barnes,et al. Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.
[89] J. Baskerville,et al. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. , 1982, The Journal of allergy and clinical immunology.
[90] G. D'Alonzo,et al. Medical chronobiology: concepts and applications. , 1993, The American review of respiratory disease.
[91] R M Ellis,et al. Circadian variation in disease activity in rheumatoid arthritis. , 1982, British medical journal.
[92] A. Reinberg,et al. Chronopharmacological study of antihistamines in man with special references to terfenadine , 1978, European Journal of Clinical Pharmacology.
[93] P. Barnes,et al. Chronobiology and asthma. I. Day-night differences in bronchial patency and dyspnea and circadian rhythm dependencies. , 1986, The Journal of asthma : official journal of the Association for the Care of Asthma.
[94] P. Patel,et al. Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma , 2005, Allergy.
[95] R. Ballard,et al. Factors related to the nocturnal worsening of asthma. , 1990, The American review of respiratory disease.
[96] R. Ballard,et al. Airways inflammation in nocturnal asthma. , 1991, The American review of respiratory disease.
[97] G. Loughlin,et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. , 1997, Chest.
[98] M. Peake,et al. Controlled Release Salbutamol Tablets versus Aminophylline in the Control of Reversible Airways Obstruction , 1989, The Journal of international medical research.
[99] M. Kaliner,et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[100] N. Eriksson,et al. A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma. , 1982, British Journal of Diseases of the Chest.
[101] A. Reinberg,et al. Circadian reactivity rhythm of human skin to house dust, penicillin, and histamine. , 1969, The Journal of allergy.
[102] W. Storms. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. , 2004, The Journal of allergy and clinical immunology.
[103] M. Kraft. Corticosteroids and leukotrienes: chronobiology and chronotherapy. , 1999, Chronobiology international.
[104] P. Barnes,et al. Reduction of nocturnal asthma by an inhaled anticholinergic drug. , 1986, Chest.
[105] R. Zuwallack,et al. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. , 1997, The Journal of allergy and clinical immunology.
[106] B. Lemmer. Chronopharmacology : cellular and biochemical interactions , 1989 .
[107] P. Barnes,et al. Effect of corticosteroids on airway hyperresponsiveness. , 1990, The American review of respiratory disease.
[108] G. D'Alonzo,et al. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing. , 1990, The American review of respiratory disease.
[109] E. Haus,et al. Biologic Rhythms in Clinical and Laboratory Medicine , 1992, Springer Berlin Heidelberg.
[110] G. D'Alonzo,et al. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. , 1995, Chest.
[111] B. Bruguerolle,et al. Recent advances in chronopharmacokinetics: methodological problems. , 1993, Life sciences.
[112] B. Lemmer,et al. Chronopharmacology and chronotherapeutics: definitions and concepts. , 1987, Chronobiology international.
[113] K. Chung,et al. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. , 2005, The Journal of allergy and clinical immunology.
[114] V. Steinijans,et al. Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin). , 1986, International journal of clinical pharmacology, therapy and toxicology.
[115] R. Djukanović,et al. Alveolar tissue inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.
[116] E. W. Swenson,et al. Flunisolide metabolism and dynamics of a metabolite , 1980, Clinical pharmacology and therapeutics.
[117] J. Palmer,et al. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.
[118] J. Moore,et al. Circadian variation in gastric emptying of meals in humans. , 1987, Gastroenterology.
[119] D. White,et al. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline. , 1989, The American review of respiratory disease.
[120] C. Soutar,et al. Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. , 1975, Thorax.
[121] P. Forsham,et al. Some clinical implications of the spontaneous diurnal variation in adrenal cortical secretory activity. , 1956, The American journal of medicine.
[122] V. Steinijans,et al. Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma. , 1987, Chronobiology international.
[123] G. M. Cochrane,et al. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. , 1975, Thorax.
[124] R. Wolstenholme,et al. Comparison of a combination of fenoterol with ipratropium bromide (Duovent) and salbutamol in young adults with nocturnal asthma. , 1989, Respiration; international review of thoracic diseases.
[125] A. Reinberg,et al. One month chronocorticotherapy (Dutimelan 8 15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. , 1977, Chronobiologia.
[126] L. García-Marcos,et al. Montelukast administered in the morning or evening to prevent exercise‐induced bronchoconstriction in children , 2006, Pediatric pulmonology.
[127] de VRIES,et al. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. , 1962, International archives of allergy and applied immunology.
[128] A. Reinberg,et al. Circadian changes in the inhibitory effects of an antihistaminic drug in man. , 1966, The Journal of investigative dermatology.
[129] J. Kemp,et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.
[130] W. Busse,et al. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. , 1992, The American review of respiratory disease.
[131] C. Chastang,et al. Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial , 1994, Allergy.
[132] H. Magnussen,et al. Circadian rhythm in airway responsiveness and airway tone in patients with mild asthma. , 1991, Journal of applied physiology.
[133] S. Clarke,et al. Sudden death in asthma. , 1979, Thorax.
[134] C. Shapiro,et al. Is nocturnal asthma caused by changes in airway cholinergic activity? , 1988, Thorax.
[135] E. Meltzer,et al. Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis , 1999 .
[136] P. Goldenheim,et al. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing. , 1987, Chronobiology international.
[137] D. Halpin,et al. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review , 2006, BMC family practice.
[138] P. Calverley,et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease , 2003, Thorax.
[139] Lúcia Rotenberg,et al. Equity and Working Time: A Challenge to Achieve , 2004, Chronobiology international.
[140] S. Wenzel,et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.
[141] R. Martin,et al. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1997, The Journal of allergy and clinical immunology.
[142] J. Palmer,et al. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.
[143] S. Szefler,et al. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma. , 2005, Chest.
[144] W. Cutting. Handbook of pharmacology , 1972 .
[145] G. D'Alonzo,et al. Progress in the Chronotherapy of Nocturnal Asthma , 1997 .
[146] M. Oellerich,et al. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. , 1985, European journal of respiratory diseases.
[147] P. Barnes,et al. Posture and theophylline kinetics. , 1985, British journal of clinical pharmacology.
[148] A. B. Kay,et al. The mode of action of anti‐allergic drugs , 1987, Clinical allergy.
[149] W. Busse,et al. Enhanced production of oxygen radicals in nocturnal asthma. , 1992, The American review of respiratory disease.
[150] I. Cox,et al. Ipratropium bromide in patients with nocturnal asthma. , 1984, Postgraduate medical journal.
[151] J. Moore,et al. Circadian Rhythm of Gastric Acid Secretion in Man , 1970, Nature.
[152] R. Davies,et al. Recurrent nocturnal asthma after exposure to grain dust. , 1976, The American review of respiratory disease.
[153] E. Meltzer,et al. Desloratadine: A new, nonsedating, oral antihistamine. , 2001, The Journal of allergy and clinical immunology.
[154] C. Dollery,et al. Circadian variation in adrenergic responses in asthmatic subjects. , 1982, Clinical science.
[155] B. Bruguerolle,et al. Rhythms in Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion , 1997 .
[156] C. Jackson,et al. Safety of Inhaled and Intranasal Corticosteroids , 2000, Drug safety.
[157] W. Pierson,et al. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. , 1990, The Journal of allergy and clinical immunology.
[158] J. Kemp,et al. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. , 2000, The Journal of allergy and clinical immunology.
[159] P. Barnes,et al. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. , 1996, American journal of respiratory and critical care medicine.
[160] D. Postma,et al. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. , 2001, The European respiratory journal.
[161] F. Halberg,et al. Circadian acrophase in peak expiratory flow rate and urinary electrolyte excretion of asthmatic children: phase shifting of rhythms by prednisone given in different circadian system phases. , 1969, Rassegna di neurologia vegetativa.
[162] S. Wenzel,et al. Theophylline: potential antiinflammatory effects in nocturnal asthma. , 1996, The Journal of allergy and clinical immunology.
[163] H. Dean,et al. Parasympathetic nervous system in nocturnal asthma , 1988, British medical journal.
[164] M. Turner-Warwick,et al. Epidemiology of nocturnal asthma. , 1988, The American journal of medicine.
[165] T. Craig,et al. The correlation between allergic rhinitis and sleep disturbance. , 2004, The Journal of allergy and clinical immunology.
[166] R. Kessler,et al. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[167] N. Konietzko,et al. [The circadian rhythm of ciliary beat frequency of human nasal cilia in probands with healthy lungs and in patients with chronic obstructive lung disease. Includes adrenergic stimulation by terbutaline]. , 1993, Pneumologie.
[168] J. Hedner,et al. Inhaled Salmeterol and Salbutamol in Asthmatic Patients , 1990 .
[169] J. English,et al. Diurnal variation in prednisolone kinetics , 1983, Clinical pharmacology and therapeutics.
[170] C. Page,et al. Theophylline--an immunomodulatory role in asthma? , 1993, The American review of respiratory disease.
[171] D. Postma,et al. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. , 2005, The Journal of allergy and clinical immunology.
[172] M. Johnson,et al. Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo , 1991, British journal of pharmacology.
[173] P. Lavie,et al. Breathing disorders in sleep associated with "microarousals' in patients with allergic rhinitis. , 1981, Acta oto-laryngologica.
[174] S. Harding. Nocturnal asthma: role of nocturnal gastroesophageal reflux. , 1999, Chronobiology international.
[175] L. Ackerson,et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1995, The Journal of allergy and clinical immunology.
[176] J. Hedner,et al. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. , 1990, The American review of respiratory disease.
[177] P. Faurschou,et al. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies , 1994, Allergy.
[178] P. Benfield,et al. Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. , 1989, Drugs.
[179] A. Reinberg,et al. Chronobiology and asthma. III. Timing corticotherapy to biological rhythms to optimize treatment goals. , 1988, The Journal of asthma : official journal of the Association for the Care of Asthma.
[180] British,et al. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. , 1977, British medical journal.
[181] A. Drollmann,et al. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[182] S. Holgate,et al. Protection against allergen-induced asthma by salmeterol , 1990, The Lancet.
[183] A. Reinberg,et al. Chronobiology in allergy and immunology , 1977 .
[184] A. Reinberg,et al. Chronobiology and asthma. II. Body-time-dependent differences in the kinetics and effects of bronchodilator medications. , 1987, The Journal of asthma : official journal of the Association for the Care of Asthma.
[185] A. Drollmann,et al. Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. , 2002, The Journal of clinical endocrinology and metabolism.
[186] T. Witek,et al. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.
[187] R. R. Babb,et al. Wheezing: a clue to gastroesophageal reflux. , 1970, The American journal of gastroenterology.
[188] D. Cockcroft,et al. Recurrent nocturnal asthma after bronchoprovocation with Western Red Cedar sawdust: association with acute increase in non‐allergic bronchial responsiveness , 1984, Clinical allergy.
[189] S. Larsson,et al. Inhaled formoterol during one year in asthma: a comparison with salbutamol. , 1991, The European respiratory journal.
[190] A. Reinberg,et al. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. , 1988, The Journal of allergy and clinical immunology.
[191] B. Ferguson. Influences of Allergic Rhinitis on Sleep , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[192] C. G. Langdon,et al. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma. , 2005, Respiratory medicine.
[193] T. Reiss,et al. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. , 1998, The European respiratory journal.
[194] P. Knauth,et al. Compensation for Unfavorable Characteristics of Irregular Individual Shift Rotas , 2006, Chronobiology international.
[195] W. Pierson,et al. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. , 1984, Pediatrics.
[196] J. Powell,et al. Albuterol Extended‐Release Products: A Comparison of Steady‐State Pharmacokinetics , 1991, Pharmacotherapy.
[197] J. Kemp,et al. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring. , 1993, Annals of allergy.
[198] R. Dahl,et al. Terbutaline sustained-release tablets in nocturnal asthma--a placebo-controlled comparison between a high and a low evening dose. , 1988, British journal of diseases of the chest.
[199] Nocturnal asthma symptoms may be more prevalent than we think. , 1994, The Journal of asthma : official journal of the Association for the Care of Asthma.
[200] Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. , 1994, JAMA.
[201] A. Reinberg,et al. Night and Shift Work and Transmeridian and Space Flights , 1992 .
[202] W. Storms. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[203] W. Busse,et al. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids , 2005, Current medical research and opinion.
[204] H. V. Bever. Recent advances in the pathogenesis of atopic dermatitis , 1992, European Journal of Pediatrics.
[205] J. Kemp. Recent Advances in the Management of Asthma Using Leukotriene Modifiers , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.
[206] B. Weeke,et al. Bambuterol: Effects of a new anti-asthmatic drug , 2004, European Journal of Clinical Pharmacology.
[207] A. Reinberg,et al. Aspects of chronopharmacology and chronotherapy in children. , 1987, Chronobiologia.
[208] M. Hetzel,et al. Is sodium cromoglycate effective in nocturnal asthma? , 1985, Thorax.
[209] A. Reinberg,et al. Circadian rhythm in total pulmonary resistance of asthmatic children. Effects of a beta-agonist agent. , 1988, Chronobiology international.
[210] G. Boccuzzi,et al. Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. , 1969, The Journal of clinical endocrinology and metabolism.